pyrazinamide has been researched along with Extravascular Hemolysis in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhosle, GS | 1 |
| Nawale, L | 1 |
| Yeware, AM | 1 |
| Sarkar, D | 1 |
| Fernandes, M | 1 |
| Colucci, G | 1 |
| Silzle, T | 1 |
| Solenthaler, M | 1 |
2 other studies available for pyrazinamide and Extravascular Hemolysis
| Article | Year |
|---|---|
Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life.
Topics: Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocyte | 2018 |
Pyrazinamide-induced sideroblastic anemia.
Topics: 5-Aminolevulinate Synthetase; alpha-Thalassemia; Anemia, Sideroblastic; Antitubercular Agents; Aza C | 2012 |